Article
PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
Journal of the American College of Cardiology - 1 Jul 2000
Kastrati A, Koch W, Gawaz M, Mehilli J, Böttiger C, Schömig K, von Beckerath N, Schömig A
Abstract excerpt
OBJECTIVE: We designed this prospective study to test the hypothesis that platelet antigen (PlA) polymorphism of glycoprotein (GP) IIIa is associated with an increased risk for adverse events after coronary stent placement. BACKGROUND: Platelets play a central role in arterial thrombosis. The PlA polymorphism of GP IIIa, a constituent of the fibrinogen receptor, may influence the platelet function and, thereby,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
